Serum 25-hydroxyvitamin D levels in hospitalized adults with community-acquired pneumonia

BRANCE ML; MILJEVIC, JULIO N.; TIZZIANI, RAQUEL; TABERNA, MARÍA E.; GROSSI, GEORGINA P.; TONI, PABLO; VALENTINI, ELINA; TREPAT, ANDREA; ZACCARDI, JULIA; MORO, JUAN; FINUCI CURI, BALTASAR; TAMAGNONE, NORBERTO; RAMIREZ, MARIANO; SEVERINI, JAVIER; CHIAROTTI, PABLO; CONSIGLIO, FRANCISCO; PIÑESKI, RAÚL; GHELFI, ALBERTINA; KILSTEIN, JORGE; STREET, EDUARDO; MORETTI, DINO; OLIVETO, VIVIANA; MARIÑO, MARCELO; MANERA, JORGE; BRUN LR

CLINICAL RESPIRATORY JOURNAL

WILEY-BLACKWELL PUBLISHING, INC

Año: 2018 vol. 12 p. 2220 - 2220

1752-6981

p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: 150%;">Introduction: Community-acquiredpneumonia (CAP) is the infectious disease with the highest number of deathsworldwide. Several studies have shown an association between vitamin Ddeficiency and increases susceptibility to respiratory tract infections. Objective:The aim of this study was to evaluate the serum 25-hydroxyvitamin D (25OHD)levels in hospitalized adults in general room with CAP. Materials and methods:An observational study was carried out in 207 hospitalized adults of both sexwith CAP over 18 years from Rosario city, Argentina (32º 52´ 18´´S) betweenJuly 2015 to June 2016. Results: 167 patients were included in the dataanalysis (59% women, 57.4±